Aim: This study determined the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) and assessed the resistance profiles of strains.
Methicillin-resistant Staphylococcus aureus among patients in a teaching hospital in Ghana Introduction
Antibiotic resistance is a global public health threat. Increasingly, high resistance rates are being reported the worldwide among several pathogens to different classes of antibiotics. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the notorious multidrug-resistant organisms causing health care and community-associated infections [1] . Since its discovery in the 1960s, resistance has been identified in this organism, and by the close of that decade, it had been implicated in hospital outbreaks in the United States, Australia, and Europe [2] . In Africa, MRSA strains were first isolated in 1978. From 1986 to 1987, a hospital outbreak was recorded in South Africa while community acquired-MRSA (CA-MRSA) infections were reported in the 1990s in Zimbabwe [3] [4] [5] .
MRSA infections are associated with increased morbidity and mortality. Other effects of MRSA may be increased medical cost resulting from prolonged hospital stay as well as limited treatment options often associated with its infections [6, 7] . MRSA are principal agents of bacteremia, pneumonia, endocarditis as well as skin and soft tissue infections [6, 8] .
Some authors have suggested that the rising incidence of MRSA in many African countries is an obvious threat to the continent [9] but in Ghana few studies have described the prevalence of MRSA [10] [11] [12] . Continuous monitoring of multidrug-resistant pathogens such as MRSA is of importance for the creation and implementation of infection control systems. This study reports the prevalence of hospital acquired-MRSA (HA-MRSA) and CA-MRSA among patients attending the Komfo Anokye Teaching Hospital (KATH) in Ghana and its susceptibility profile to some relevant antibiotics.
Materials and Methods

Ethical approval
Ethical approval was sought and obtained from the Committee on Human Research, Publication and Ethics, the joint ethics committee of Kwame Nkrumah University of Science and Technology and Komfo Anokye Teaching Hospital in Kumasi, Ghana. Patients consent was sought, and those that agreed to participate in the study were recruited. All specimens were coded, and patients made anonymous by removing identities on samples.
Study population and site
This study was conducted at the Microbiology Laboratory of the KATH, Kumasi which is the only tertiary health institution in the Ashanti Region and the second largest in Ghana. It is a referral hospital of 1200 bed capacity which serves eight regions in Ghana. Patients of all age groups presenting with bloodstream infections as well as skin and soft tissue infections who gave their consent were recruited in the study from October 2006 to March 2007. HA-MRSA was defined as, isolates from all inpatients and outpatients (who have had surgery or been hospitalized within the year), and for CA-MRSA, isolates from all outpatients who have not had surgery or hospitalization within the year of the study. The information for categorization into HA-MRSA and CA-MRSA was obtained through interviews and questionnaire administration.
Sample collection, isolation, and identification
Inpatients and outpatients diagnosed with sepsis and skin and soft tissue infections whose blood, pus and swab samples were brought into the laboratory for bacteriological analysis were approached for enrollment into the study. Inpatients whose samples tested positive for MRSA were followed up at the various wards and interviewed using a questionnaire. In addition, outpatients who were diagnosed as MRSA positive cases were interviewed. Nurses and medical assistants in the ward assisted in the filling and collection of questionnaire forms of inpatients. Interview and filling of questionnaire forms of outpatients were done when they came for their medical reports from the laboratory. The interview confirmed the information in the medical records. The questionnaire provided the risk factors for grouping the isolates into HA and CA infections.
Blood, pus, wound, nasal, and ear swabs were processed using standard bacteriological methods. Colonies morphologically resembling S. aureus were Gram-stained and biochemical test including catalase, slide, and tube coagulase test were carried out to confirm the species.
Antibiotic susceptibility test
Susceptibility test was performed on Mueller-Hinton agar (Becton Dickinson, UK) using the Kirby-Bauer disc diffusion technique [13] . The following antibiotics at given concentrations were used: Penicillin (1.5 U), ampicillin (10 μg), gentamicin (10 μg), erythromycin (5 μg), tetracycline (10 μg), cefuroxime (30 µg), flucloxacillin (5 µg), and co-trimoxazole (trimethoprim-sulfamethoxazole (25 µg), (Mast Diagnostics, UK). Methicillinresistance was tested using 1 µg oxacillin disc cartridges (OXOID, UK). Zone diameters were read after incubation at 35°C for a full 24 h. Strains with zone sizes of <10 mm for oxacillin were regarded as methicillin resistant, or any growth within the zone of inhibition was indicative of methicillin resistance [13] . Oxacillin minimum inhibitory concentrations (MICs) were determined with the E-test strips (AB Biodisk, Solna, Sweden) on 50 MRSA isolates using 0.5 McFarland density inoculum following the manufacturer's instructions. Methicillin susceptibility and methicillin resistance were defined as oxacillin (OXA) E-test MICs of =2 and =4 µg/ml, respectively. S. aureus ATCC 25923 was the quality control strain.
Statistical analysis
Statistical analysis was performed using analysis of variance with logistic regression analysis performed to find an association between variables. A p≤0.05 was considered statistically significant. Stata 14.0 software was used for statistical analysis.
Results
Demographic distribution showed 61% of cases came from females. The mean age of the study group was 11 years, with an age span from <1 to 85-year-old (Table-1 Of the 250 S. aureus isolated, 87 were resistant to oxacillin giving an MRSA prevalence of 34.8%. Out of the 87 MRSA isolates, HA-MRSA was 67 (26.8%), and 20 (8%) was CA-MRSA. The difference in isolation rates was not statistically significant, p=0.9.
The 250 samples processed included 211 blood (84.4%), 19 wound swabs (7.6%), 8 pus (3.2%), 6 ear swabs (2.4%), 2 peritoneal fluid (0.4%), 2 nasal swabs (0.4%) and 1 each of knee, and pleural aspirates (0.4%). Of the 87 MRSA recovered, 86.2% (75/87) was isolated from blood and the remaining 13.8% (12/75) from miscellaneous samples (pus -1.1%, nasal swab -1.1%, ear swab -2.3%, and wound swab -9.2%). The distribution of MRSA infections at the various departments of the hospital was 46.3% (31) from the mother and baby unit (MBU), 40.3% (27) for pediatric unit, 3% (2) each from male surgical and women medical unit, 3% (2) from outdoor patient and the remaining 1.5% from postnatal and medical emergency unit. Sepsis and septicemia were the most reported infections in HA-MRSA (58.1%) followed by pneumonia (8.9%) as sepsis was the leading infection in CA-MRSA (40%) followed by ear infections (10%). Susceptibility profiles of HA and CA isolates were 100% each to penicillin and ampicillin. With the exception of cefuroxime and erythromycin in which resistance was below 50%, the remaining antibiotics showed rates ranging from 50% to 100% (Table-2 ). There was no significant difference in resistance rates of HA and CA isolates (p=0.76).
The E-test showed all 50 MRSA isolates were resistant to oxacillin and 34 and 41 of the isolates were resistant to gentamicin and cotrimoxazole, respectively, with MIC range of 4-256 to oxacillin, 0.125-256 to gentamicin, 0.064-32 to cotrimoxazole, and 1.5-32 to ceftriaxone (Table-3 ).
Discussion
Globally, MRSA has been recovered from different clinical samples at a prevalence range of 23-73% [14] . In most African countries, the prevalence was <50% before the year 2000 but has seen an increased trend in recent times with an exception to South Africa [9] . Few studies that have looked at MRSA prevalence in Ghana showed an ambit of 16.6-47.3% [10, 11, 12, 15] . Our study found MRSA prevalence of 34.8% which is consistent with reported rates in Ghana and other countries including France, Saudi Arabia, Kenya, and Cameroon [10, [16] [17] [18] but lower than the 44.2% reported in Nigeria [19] .
Traditionally, MRSA is considered a major nosocomial pathogen in health-care facilities but its involvement in community-associated infections have also been established [5, 20] . According to Zetola et al. [20] , CA-MRSA did not develop in the community but constitutes a hybrid between MRSA which escaped from the hospital environment.
MRSA bacteremia is mostly associated with higher mortality and may have serious sequelae in infants and children [7] . In our study, MRSA was 74.7% prevalent among patients aged <1-9 years and this could be due to the fact that the Microbiology Department of KATH receives the bulk of blood samples from the MBU and pediatric emergency unit and consequently, MRSA was isolated mainly from blood stream infections (86.2%). MRSA outbreaks in neonatal intensive care units are well documented [21] , and young children tend to have higher colonization rates probably because of their frequent contact with respiratory secretions [22] . In Ghana, an MRSA outbreak was recorded at the children's ward of the Korle-Bu Teaching Hospital [23] .
The resistance profile of MRSA isolates revealed generally high resistance to the β-lactams (penicillin and ampicillin), cotrimoxazole and tetracycline but lower rates (<50%) were recorded for cefuroxime and erythromycin. Some studies have also established high resistance (100%) to the β-lactams [19, 24, 25] , 80% to cotrimoxazole [26] , as well as 78.7% and 86.8% to tetracycline [19, 27] .
In vitro resistance to gentamicin is a good surrogate marker of nosocomial acquisition of MRSA and conversely, CA strains of MRSA are usually gentamicin-susceptible in vitro [28, 29] . This was affirmed in our study, where 70.1% of HA-isolates were resistant and 25% of CA isolates were resistant to gentamicin. Among aminoglycosides, 65.8% resistance has been reported in Nigeria [19] , and 90% in Eastern Uttar Pradesh [26] .
A significant proportion of MRSA isolates was resistant to flucloxacillin which is of concern because it is the drug of choice for treating S. aureus infections in this hospital. The relatively low resistance recorded against cefuroxime may be attributed to the cost of the drug as they are rarely prescribed by physicians at KATH compared to the cheaper drugs such as penicillin, ampicillin, erythromycin, gentamicin, and tetracycline. Furthermore, patients and potential drug abusers are discouraged from its purchase due to the high cost. A limitation of this study was our inability to test vancomycin which is the drug of choice for multi-resistant MRSA. At present, in Ghana MRSA is not included in the infections under surveillance because it is not considered a public health problem, but continuous monitoring of its prevalence and susceptibility patterns in our regional and district hospitals are necessary for effective management and control.
Conclusion
MRSA was prevalent among 34.8% of patients attending KATH with HA-infections being common. Resistance to penicillin, ampicillin cotrimoxazole, flucloxacillin, and tetracycline was generally high but 
